Jim and Jeff discuss the analyst price target increase for Microsoft. They also talk about the weight loss drug opportunity for Viking Therapeutics. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake
Squawk on the Street
Cramer's Morning Take: Microsoft & Viking Therapeutics 3/26/24
Jim and Jeff discuss the analyst price target increase for Microsoft. They also talk about the weight loss drug opportunity for Viking Therapeutics. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake
CNBC Investing Club Disclaimer
- Duration:
- 5m
- Broadcast on:
- 26 Mar 2024
- Audio Format:
- mp3
electricity a big idea that's inspired countless new ones from powering the light bulb to virtually powering our entire lives 30 years ago State Street launched the spider S&P 500 ETF spy a big idea that inspired the world to invest differently and still does what can you do with spy before investing consider the funds investment objectives risks charges and expenses visit scea.com for a prospectus containing this another information really carefully before investing spies subject to risks similar to those of stocks all ETFs are subject to risk including possible loss of principal offs distributing distributors Jim Kramer here to share with you a sample of my take on the market from today's CBC investing club morning meeting just to get back to some market story say there was a price targeting piece on wet bus shave big focus on co-pilot right based on their checks they think momentum is building around co-pilot adoption that's the AI tool that you can use when someone came out of 470 and said that's not being used there was a there was a I think this was in the Wall Street Journal about perhaps maybe it's not worth the price but there's going to be a button on your PC right so it was a big thing last week Microsoft they've revealed their new surface pro 10 and laptop 6 that have that dedicated co-pilot feature that essentially makes it three calm you can use generative AI applications very seamlessly with that this is where people were making this judgment that it's not like now I will tell you that versus quad 3 I think what three superior a quad 3 is pros and this one she chechi piece a little more robotic but you get the right answers for the most part yeah well I think the big takeaway here from the web bush nerd at least is that look they're obviously Microsoft has a massive installed base they think 70% of that will adopt co-pilot which will obviously be huge for revenues I mean I think that people have to understand that Microsoft also has no problem with the Justice Department you know they went after me 2000 they not going after this time it's surprising that they haven't given the fact that they're so powerful but what a performer now we can have a daily I'll talk about the obesity space now by the way Larry Fink tonight talks about the obesity space and how important it is for people living longer he's basically saying these are the drugs that will extend your life okay yeah so obviously this Viking therapeutic is coming back as being something that is a threat to Eli Lilly this time it's because of a pill that is that is more efficacious at least in phase one yeah yeah it's phase one data hard to make an apples to apples comparison so its data showed a 5.3% weight loss reduction at 28 days so you know four weeks well lilies I mean they're further ahead phase two but it showed 14.7% mean weight at reduction at 36 weeks so we're on a different scale here but look I and keep in mind also that Eli Lilly already investing in manufacturing capacity for the pill ahead of phase three ahead of potential FDA approval because they are so confident I know join the CBC investing club with Jim Kramer catch my member exclusive warning meetings every day at 10 20 a.m. visit cmbc.com slash morning take to become a member today that's one word morning take all opinions expressed by Jim Kramer on this podcast and in connection with the CNBC investing club are solely Kramer's opinions and do not reflect the opinions of CNBC NBC Universal or their parent company or affiliates and may have been previously disseminated by Kramer on television radio internet or another medium no specific outcome or profit is guaranteed in connection with your alliance upon or other use of the content from Kramer the opinions offered in connection with this podcast in the CNBC investing club are not an attempt to induce any particular trading behavior investment or strategy you should be aware of the risk of loss and following any strategy or investment discussed in the content from Kramer to view the full CNBC investing club disclaimer please visit cmbc.com forward slash investing club disclaimer the spirit of performance defines Acura and now it's electric introducing the all-electric zdx accurate is most powerful SUV yet while what powers their cars may change the energy that makes Acura never will crafted using the same formula that brought them electrified supercars and multiple MSA championships the zdx has tracked tested performance that packs an energy all its own with a premium bang and olives and sound system and up to 313 mile range on a single charge and a type S variant with an estimated 500 horsepower the zdx is everything they said electric could never be it was built with the driver in mind just like Acura has been doing since the beginning we could talk all day but the only way to experience this electric performance is to drive it yourself unlock the energy and order yours at Acura.com